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Objectives . This study assessed whether aging is associated with
progressive endothelial dysfunction, whether the pattern of any
age-related decline in vascular health is different in urea and
women and whether any gentler difference is consistent with
known changes in hormonal status.
Background. Coronary and cerebrovascular disease are much
less common in young and middle-aged women compared with
men, although the gender difference in death from atherosclerosis
is less marked after the menopause . Endothelial dysfunction is an
early event in atberogenesis send is important in dynamic plaque
stenosis in later life. Ile effect ofaging on endothelial function in
men and women, however, is not well known.
Methods. We used high resolution ultrasound to study endo-
thelium-dependent and endothelium-independent vascular re-
spouses . Brachial artery physiology was investigated in 238 sub-
jects (103 men, 135 women; mean [tSD] age 38 ± 17 years, range
15 to 72) with no known risk factors for atherosclerosis . The
responses to reactive hyperemia (slow-mediated dilation, which is
Life expectancy is greater for women than for men, in large
part because of their lower incidence of cardiovascular death
in middle age (1). Male gender remains a cardiovascular risk
factor, even after controlling for other influences, such as
cigarette smoking and hypertension (2,3) . Many investiga-
tors have suggested that the basis for the protection of young
and middle-aged women from atherosclerosis is their relative
excess of estrogenic hormones (4-6) .
Endothelial dysfunction is an important early event in
experimental models of atherosclerosis (7) . It has recently
been demonstrated in asymptomatic children and young
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endulkelhim dependent) and to glyceryl trinitrate (an endothelimn
tindependent dilator) were assessed for all the subjects and then for
men and women separately .
Resalls . On multivariate analysis for the whole group, reduced
flow-mediated dilation was related to older age (r = -6 .34, p <
0. 1). In urea, Pow-mediated dilation was preserved in subjects
aged !!540 years but declined thereafter at 0 .21 %/year. In women,
flow-mediated dllatl5ii was stable until the early 50s, after which
it declined at 0.49%lyear (p = 0.002 compared with men) . In
contrast, there was no significant change in the glyceryl trinitrate
response with aging in either gender.
Conclusions. Aging is associated with progressive endothelial
dysfunction ha normal humans, and this appears to occur earlier
in men than in women. In women, however, a steep decline
commences at around the time of the menopause . This is censist
tentwith a protective effect of estrogens on the arterial wall .
(J Am Coll Cardiol 1994;24 :471®6)
adults with vascular risk factors (8) and may contribute to
morbidity and mortality by disturbing arterial physiology in
adults with established coronary stenoses (9,10) . Previous
studies have shown that increasing age is associated with
coronary endothelial dysfunction but have only examined
small numbers of subjects, most of whom had multiple
vascular risk factors and were undergoing catheterization for
suspected coronary artery disease (11,12) . Using a noninva-
sive method, we examined endothelial function and its
relation to age in a large number of healthy men and women
who did not have these potentially confounding influences .
Our observations suggest that there is a difference in the
pattern of age-related vascular injury in men and women,
with a steep decline in endothelial function occurring in
women after the menopause . This supports the concept of a
hormonal influence on vascular disease and risk .
Methods
Subjects. We studied 238 subjects (103 men, 135 women
;
mean [±SD] age 38 ± 17 years, range 15 to 72) recruited
from hospital staff, families, friends and community volun-
0735-10971941$7 .00
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teers over a 2-year period . Subjects were included only it
they were asymptomatic, lifelong nonsmokers and had no
family history of premature vascular disease
. None were
known to have hypertension, diabetes or hyperlipidemia
.
Because cholesterol levels increase with age in a normal
population, we included all subjects with total cholesterol
below the 90th centile for their age and gender (13). No
subjects were taking regular medications . Thirty-six of the
women had not had a menstrual period for >1 year ; their
average age at menopause was 51 ± 1 years . None of these
postmenopausal women was taking hormone replacement
therapy. All studies were approved by the local ethics
committee .
Study design . Total plasma cholesterol and rest supine
blood pressure were measured in every subject . All then had
a noninvasive ultrasound study of the right brachial artery to
test endothelial and smooth muscle function, as previously
described (8) . Arterial diameter was measured at rest, during
reactive hyperemia, again at rest and after administration of
sublingual glyceryl trinitrate, using a standard 7 .0-MHz
linear array transducer and 128 XP/10 system (Acuson) .
Previous investigators have demonstrated that conduit ar-
tery dilation in response to flow increase is endothelium
dependent (14,15), whereas the dilator response to glyceryl
trinitrate is endothelium independent (9,16) . Hyperemic
microvascular responses are also endothelium indepen-
dent (17) .
Each subject lay at rest for at least 10 min before the first
rest scan was obtained . Increased flow was then induced by
inflation of a pneumatic tourniquet placed around the fore-
arm to a pressure of 300 mm Hg, followed by deflation after
4.5 min . The second scan was taken for 30 s before and 90 s
after cuff deflation . Fifteen minutes was then allowed for
vessel' recovery, and a further rest scan was then recorded,
Sublingual glyceryl trinitrate spray (400 µg) was then admin-
istered, and 3 to 4 min later the last scaai was done . Seven
subjects declined sublingual glyceryl trinitrate. Doppler-
derived flow measurements were obtained during the first
rest scan and again during the 1st 15 s of reactive hyperemia .
The electrocardiogram (ECG) was monitored continuously
throughout the study .
Data , tli scans were recorded on super VHS
videotape for later analysis. Vessel diameter was measured
by two independent observers unaware of the clinical details
and stage of the experiment, as described previously (8). The
mean vessel diameter and percent dilation for each patient
were taken as the aver a of the measurements of the two
observers .
Statistics. The distributions of flow-mediated dilation,
glyceryl trinitrate response, age, cholesterol, vessel size and
hyperemia were summarized by sample means and standard
deviations, and pairwise relations were expressed by Pear-
son correlation coefficients . Treating flow-mediated dilation
and glyceryl trinitrate dilation as response variables and age,
cholesterol and vessel size as independent variables, we
investigated their simultaneous relation by multiple regres-
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sion analyses, from which we obtained partial correlation
coefficients. Men and women were then analyzed separately .
For flow-mediated dilation, a multiple regression was
carried out with a "vessel size" term plus two "age" terms,
with coefficients depending on whether the subject's age was
above or below a specified change point t,,,, x . Thus, for age
below the change point t, the regression model is Flow-
mediated dilation = a + b(Size - Mean size) + c(Age -- t),
where Mean size is the mean vessel size, whereas for age
above the change point, the model is Flow-mediated dilation
= a + b(Size - Mean size) + d(Age - t) . The "most likely"
change point t m~x produced the minimal residual standard
deviation rTto„~x over a range of possible change points from
30 to 65 years . To summarize the support for each possible
change point I, the "profile likelihood" o,,,,,,,/o,1 was plot-
ted, which has maximal I at t = as derived from a
likelihood ratio test procedure (18) . To validate the two-
straight-line model compared with a smooth curve, a qua-
dratic function in age was also fitted to the data, the
calculated residual standard deviation was smaller for the
two-straight-line model. Men and women were compared
with respect to the gradient of adjusted flow-mediated dila-
tion with age, both before and after their estimated change
point, using a Z test based on their estimated standard
errors. For glyceryl trinitrate, the regression coefficient b
arose from a simple linear regression on vessel size ; that is,
Glyceryl trinitrate = a + b(Size - Mean size) .
For each subject, flow-mediated and glyceryl trinitrate-
induced dilation were adjusted for vessel size by subtracting
b(Size - Mean size), and these adjusted values were then
plotted against age .
Results
The age distribution of the subjects and their vascular
responses to increased flow and to glyceryl trinitrate are
shown in Figures 1 and 2 . Scans from all 238 subjects were
of sufficient quality for analysis, and no plaques were ob-
served in any subject . Total plasma cholesterol was 191 ± 39
mg/dl (range 101 to 299) . and there was a positive correlation
between age and cholesterol level (r = 0 .58, p < 0 .01). No
subjects were hypertensive (blood pressure < 160/90 mm Hg
in all). In response to an increase in flow of 487 ± 172% after
cuff deflation, there was an increase in brachial artery
diameter of 7 .9 ± 3.9% (range - 1% to 18%) . There was no
correlation between age and degree of reactive hyperemia
(r = -0 .06, p = 0 .49) or between flow-mediated dilation and
hyperemia (r - 0.09, p = 0.16). In response to glyceryl
trinitrate, arterial diameter increased by 19 .4 ± 5.8% (range
4% to 38%) .
On multivariate analysis of all subjects, flow-mediated
dilation was independently related to age (r = -0 .34, p <
0.0001) and vessel size (r = -0.35, p < 0 .0001) but not to the
cholesterol level (r = -0 .09, p = 0.14) . In contrast, although
the glyceryl trinitrate response was also related to vessel size
JACC Vol . 24, No . 2
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Figure 1 . Aging and flow-
mediated dilation (FMD) in 103
men (left) and 135 women (right) .
Top, Individual data points for
percent flow-mediated dilation ad-
justed for vessel size . Bottom,
.,a point ex-
isting
	
of a change
ting at any given age ; this is
highest for men at age 41 years
and for women at 53 years. In
women, there is a steeper decline
in flow-mediated dilation after
their change point .
10 20
FMD adjusted for vessel size
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Support tar changapoint
-0.45, p < 0 .0001), there was no relation with age
-0.10, p -- 0.18) (Table 1) .
Gender difference, In men, flow-mediated dilation (ad-
justed for vessel size) did not decline until the end of the
fourth decade . Change-point analysis suggested that an
age-related decline occurred subsequently, from -41 years
of age, after which flow-mediated dilation decreased by
Figure 2 . Aging and glyceryl trinitrate (M)-induced dilation in
102 men (top) and 129 women (bottom) . The response to glyceryl
trinitrate is preserved with increasing age in both genders . Seven of
the 238 subjects had a decline in glyceryl trinitrate .
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0.21%/year . In contrast, flow-mediated dilation was pre-
served in women until the early 50s (most likely change point
at age 53 years), after which it declined significantly faster
than in men (0.49%)year, p = 0.002) . There was a very
narrow range in the age at menopause in this study, and
separate analysis of years since menopause versus flow-
mediated dilation in women yielded a similar slope of de-
cline . In contrast, there was no age-related decline in glyc-
eryl trinitrate-induced dilation in either gender .
Discussion
This study showed that aging is associated with progres-
sive loss of flow-mediated dilation in the systemic arteries of
healthy subjects with no risk factors for vascular disease . In
contrast, responses to glyceryl trinitrate are preserved into
old age, and this suggests that aging leads to endothelial
dysfunction . Because there is no age-related change in the
hyperemic flow response, it is unlikely that progressive
proximal atherosclerosis could explain the arterial vasodila-
tor abnormalities observed in this study .
We also observed that the pattern of age-related
changes
in arterial physiology is different in men and women . In men,
endothelial responses decline gradually after the fourth
decade, whereas in women, vascular physiology remains
healthy for a further 10 years . Subsequently, the rate of
decline is faster in women, so that endothelial dysfunction is
present in almost all subjects by 65 years of age
. This pattern
of vascular damage parallels the known difference between
the genders in cardiovascular morbidity and mortality in
middle and old age (1,19),
where men are at much higher risk
from age 40 to 50 years, but women "catch up" in later life .
The process of atherosclerosis does not appear to differ
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Table 1. Results of Multiple Regression Analysis for Determinants of Flow-Mediated Dilation
(an endothelium-dependent response) and Glyceryl Trinitrate-Induced Dilation
(an endothelium-independent response)
FMD = flow-mediated dilation
; GIN ® glyceryl trinitrate-induced response,
between men and women, and the risk factors known to
predispose to vascular disease affect both genders equally
(20) . We have previously shown that this noninvasive
method can detect flow-mediated dilation in healthy subjects
and that risk factors such as hypercholesterolemia (21) and
cigarette smoking (22) are associated with abnormal endo-
thelial physiology in both male and female children and
young adults . Aging is associated with an increasing preva-
lence of diabetes, hypertension and hypercholesterolemia,
and in the previous studies of both Vita et al . (11) and Yasue
et al . (12) . in which coronary endothelial dysfunction was
found in most subjects >30 years of age, risk factors may
have had an important confounding effect .
Study furltations. In this study, by excluding all subjects
who had ever smoked or who had known hyperlipidemia,
hypertension, diabetes or a positive family history, we in-
vestigated the effects of aging per se on vasomotor responses
and compared endothelial function in male and female
subjects Previous studies enrolled too few patients to ex-
amine any gender differences in the effects of aging on
endothelial function (11, 12) . The method we used to study
endothelial and smooth muscle function is noninvasive and
well tolerated, allowing investigation of a large number of
subjects with neither risk factors nor symptoms . The accu-
racy of 7
.0-MHz ultrasound is sufficient to allow detection of
small diameter differences (as little as 0 .1 mm), and the
reproducibility of the technique has been established previ-
ously (8,22,23). Although only superficial systemic arteries
can be studied, atherosclerosis is a diffuse process, and there
is a correlation between the presence of disease in different
large arteries in the same subject (24) . Recently two groups
have reported that brachial artery vasomotor responses are
well correlated with coronary endothelial physiology and
coronary atherosclerosis (25,26) .
and the ovascular system. Aging is associated
with a number of anatomic and hemodynamic changes in the
vascular system of all subjects, including collagen degener-
ation, loss of elastin, increased intima-media thickness of the
arteries and reduced vascular compliance (27,28)
. Despite
these age-related changes, the arterial response to glyceryl
trinitrate was preserved in our study . This is consistent with
other studies that have shown that pharmacologic doses of
JACC Vol. 24. No. 2
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exogenous nitrovasodilators remain effective in older adults
(29,30) and that these drugs are still therapeutically effective
in geriatric patients (16) . In contrast, we observed an age-
related decline in endothelial function in both men and
women. Previous investigators have shown that the dilator
capacity of both large and small coronary vessels in response
to acetylcholine, an endothelium-dependent vasodilator,
also decreases with increasing age in subjects with chest pain
but angiographically smooth coronary arteries (11,12,31) .
The mechanism whereby aging is associated with im-
paired endothelial function is not known . Possibilities in-
clude an age-related decrease in release of endothelium-
derived relaxing factor(s), or their increased catabolism in
the vessel wall, or increased release of constricting factors
(31) . In vitro aging is associated with increased monocyte-
endothelial cell adherence, which may result from age-
related increases in peroxidative stress (32) . Our data sug-
gest that women may be protected from these age-related
changes for a decade longer than men .
Gender differences. This gender difference in the pattern
of age-related decline in endothelial function is best ex-
plained by the influence of hormonal factors . Estrogens may
protect women from atherogenesis (33,34) . After the meno-
pause, decreased estrogen levels are associated with a more
atherogenic lipid profile (19,35) ; however, the effects of
estrogen on plasma lipids can explain only a small part of the
beneficial effects on the risk of vascular disease (36) . Estro-
gens are vasoactive hormones and have direct effects on the
arterial wall (37,38). In experimental animals, surgically
induced menopause is associated with a loss of endothelium-
dependent coronary vasorelaxation (39) . In postmenopausal
animals, estrogen replacement may restore normal endothe-
lial function (6). Intravenous estrogen acutely improves
endothelium-dependent vasorelaxation in postmenopausal
women with coronary artery disease (40), and sublingual
estrogen has a beneficial effect on myocardial ischemia in
similar patients (41) . In our study, the age at which endothe-
lial dysfunction was seen in women was around the time of
the menopause. These data therefore suggest, but do not
prove, that estrogens may protect against endothelial injury .
Injury of the endothelium is important both because it is
a key early event in atherogenesis and because it may
FMD GIN
Coefficient
(SD)
Partial
Correlation
Coefficient P Valve
Coefficient
(SD)
Partial
Correlation
Coefficient
	
p Value
Age (yr)
. (0.02) -0.34 < 0.0001 -0.03 (0.02) -0.10 0 .18
Vessel size (mm) -2 .13 (0.33) -0 .35 < O.Ot0I -4.01(0.54) -0 .45 < 0.11
Cholesterol (10 mgfdl) -0 .09 (0 .06) -0 .09 0.14 --0 .08 (0 .10) -0 .06 0 .41
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increase risk in subjects with established atherosclerosis by
predisposing to vasoconstriction and thrombosis (9) . The
recent demonstration that L-arginme, the precursor of
endothelium-derived relaxing factor, not only protects the
endothelium but also retards atherosclerosis in the
cholesterol-fed rabbit suggests that endothelial dysfunction
may be intimately involved in the pathogenesis of atherotna
(42) .
Clinical i plications . Cardiovascular disease is the most
common cause of death in the United States, and the known
gender difference in life expectancy is largely related to the
increased risk of coronary and carotid atherosclerotic com-
plications in middle-aged men, Our data suggest that aging
per se, irrespective of exposure to known risk factors, may
be associated with earlier physiologic abnormalities in the
systemic arteries of men compared with women . This is
consistent with observations that both old age and mate
gender arc independent risk factors for cardiovascular mor-
tality and that estrogens may protect women from the
age-related decline in vascular health . The association be-
tween menopause and the subsequent change in endothelial
function that we have observed is provocative, but prospec-
tive studies will be required to see whether hormone replace-
ment therapy prevents or retards the age-related changes in
arterial physiology in postmenopausal women . Many such
women are potentially candidates for hormone replacement
therapy, not just for well-being and prevention for osteopo-
rosis but also for protection of the arterial wall and reduction
of vascular risk. The availability of a noninvasive method to
assess ",ascular health will allow investigation of the appro-
priate type and timing of such hormonal therapy, both in
individual subjects and in clinical trials .
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